Key trends shape the managed markets landscape

Share this article:
Managed markets has moved from behind the scenes to center stage and key trends are shaping the landscape and environment in ways not even considered a few years ago:
  • Political: Healthcare reform, increasing government oversight and stricter regulations are redefining the rules of engagement between pharmaceutical companies and stakeholders, especially as 32 million new covered lives enter the system without a proportionate increase in the number of healthcare providers.
  • Economic: A shift to evidence-based economic value has increased the need for pharmas to demonstrate how their products and services are improving patient outcomes; comparative effectiveness studies are being required to determine appropriate treatment options.
  • Social: Online social networks have empowered patients, who now demand more choices and control over their treatment.
  • Older adults: An aging population with a prevalence of chronic diseases could tax the resources of Medicare and providers.
  • Time: Physicians have less time and more patients, so their interactions have to be meaningful and efficient.
  • More options: Pharmacogenomics and personalized medicine have broadened the scope of treatment choices—especially in oncology—but some of these options can be costly and their benefits need to be proven.
  • Legal: High levels of regulatory control and ongoing industry relationships are under greater scrutiny.
  • Technology: Seamless flow of unfiltered data is shared by key stakeholders and influences choices; using multimedia channels is essential for ensuring effective messaging.
Understanding how these trends influence targeted stakeholders provides new communication opportunities. Patients have unfettered access to information, there is more data transparency due to regulatory requirements, and all stakeholders have better digital connectivity. Employers now offer wellness and disease management programs to control rising premiums. Plans leverage technology to engage members and improve patient outcomes.

With the spotlight now focused on managed markets, marketing communications require a more holistic blend of content, commerce, community and connectivity.

Kim Wishnow-Per IS EVP managing director, Torre Lazur Managed Markets
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters